Mark E. Sherman
#115,579
Most Influential Person Now
Mark E. Sherman's AcademicInfluence.com Rankings
Mark E. Shermanmedical Degrees
Medical
#1655
World Rank
#2018
Historical Rank
Oncology
#80
World Rank
#84
Historical Rank
Mark E. Shermanbiology Degrees
Biology
#6673
World Rank
#9437
Historical Rank
Computational Biology
#114
World Rank
#114
Historical Rank
Genetics
#628
World Rank
#712
Historical Rank
Molecular Biology
#706
World Rank
#723
Historical Rank
Download Badge
Medical Biology
Mark E. Sherman's Degrees
- Bachelors Biology University of California, Berkeley
- PhD Genetics Stanford University
Similar Degrees You Can Earn
Why Is Mark E. Sherman Influential?
(Suggest an Edit or Addition)Mark E. Sherman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Integrated Genomic Analyses of Ovarian Carcinoma (2011) (6411)
- Comprehensive molecular characterization of human colon and rectal cancer (2012) (6141)
- Comprehensive molecular characterization of gastric adenocarcinoma (2014) (4496)
- The 2001 Bethesda System: terminology for reporting results of cervical cytology. (2002) (3229)
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective (1995) (3227)
- Comprehensive genomic characterization of squamous cell lung cancers (2012) (2998)
- Comprehensive genomic characterization of head and neck squamous cell carcinomas (2015) (2860)
- The Immune Landscape of Cancer (2018) (2766)
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. (2015) (2211)
- The Molecular Taxonomy of Primary Prostate Cancer (2015) (2116)
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
- Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. (1995) (1300)
- Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. (1993) (1237)
- Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. (2017) (1092)
- The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. (2005) (1060)
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies (2010) (1025)
- Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. (2016) (931)
- Association analysis identifies 65 new breast cancer risk loci (2017) (922)
- Menopausal hormone replacement therapy and risk of ovarian cancer (2002) (617)
- Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. (2004) (616)
- Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. (1999) (598)
- Persistence of type-specific human papillomavirus infection among cytologically normal women. (1994) (580)
- The carcinogenicity of human papillomavirus types reflects viral evolution. (2005) (565)
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2018) (559)
- Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. (2011) (536)
- Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. (2006) (514)
- Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
- Theories of Endometrial Carcinogenesis: A Multidisciplinary Approach (2000) (488)
- Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study (2007) (474)
- Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) (2011) (447)
- Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. (2003) (446)
- Performance of common genetic variants in breast-cancer risk models. (2010) (430)
- Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000 (2004) (415)
- Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. (1995) (414)
- Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study (2002) (413)
- Genome-wide association studies identify four ER negative–specific breast cancer risk loci (2013) (411)
- A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. (2005) (394)
- Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics (2008) (390)
- Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. (2005) (368)
- Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. (2010) (347)
- p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. (1995) (341)
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. (2013) (339)
- Uterine Serous Carcinoma A Morphologically Diverse Neoplasm With Unifying Clinicopathologic Features (1992) (326)
- Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. (1996) (317)
- Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. (1995) (307)
- A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. (2001) (301)
- High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). (2001) (296)
- Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). (2002) (275)
- Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. (2009) (274)
- HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica (2001) (268)
- Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine (2011) (259)
- An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). (2001) (258)
- Viral load of human papillomavirus and risk of CIN3 or cervical cancer (2002) (258)
- The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship (2016) (256)
- Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. (1999) (253)
- Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials. (2015) (252)
- A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. (2002) (251)
- Recent trends in breast cancer among younger women in the United States. (2008) (249)
- Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. (2011) (247)
- International patterns and trends in ovarian cancer incidence, overall and by histologic subtype (2017) (242)
- Human papillomavirus type 16 variants and risk of cervical cancer. (2001) (225)
- A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. (2010) (224)
- Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. (1994) (216)
- How many etiological subtypes of breast cancer: two, three, four, or more? (2014) (213)
- CIN2 Is a Much Less Reproducible and Less Valid Diagnosis than CIN3: Results from a Histological Review of Population-Based Cervical Samples (2007) (213)
- Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. (1997) (211)
- Comparison of PCR- and Hybrid Capture-Based Human Papillomavirus Detection Systems Using Multiple Cervical Specimen Collection Strategies (1998) (211)
- Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. (2000) (207)
- Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling (2015) (202)
- Utility of liquid‐based cytology for cervical carcinoma screening (1999) (201)
- Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. (2011) (192)
- Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
- Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. (2002) (186)
- Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus (2003) (185)
- Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? (1997) (178)
- Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection (2004) (176)
- Mortality trends for cervical squamous and adenocarcinoma in the United States (2005) (174)
- Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections. (2010) (173)
- Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. (2001) (172)
- Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. (2013) (170)
- Comparisons of HPV DNA detection by MY09/11 PCR methods (2002) (169)
- Survival among women with borderline ovarian tumors and ovarian carcinoma (2004) (167)
- Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study (2009) (165)
- PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2 (2012) (165)
- CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. (2012) (164)
- High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease (2007) (159)
- Relationship of Benign Gynecologic Diseases to Subsequent Risk of Ovarian and Uterine Tumors (2005) (158)
- Established breast cancer risk factors by clinically important tumour characteristics (2006) (158)
- Comparison of Age Distribution Patterns for Different Histopathologic Types of Breast Carcinoma (2006) (155)
- Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica. (2011) (153)
- Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. (2012) (145)
- Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. (2004) (144)
- Application of Biomarkers in Cancer Epidemiology (1997) (144)
- Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. (1997) (143)
- A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. (2003) (142)
- Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica (2003) (140)
- Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. (2004) (140)
- Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico (2003) (139)
- Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. (1999) (139)
- Using deep convolutional neural networks to identify and classify tumor-associated stroma in diagnostic breast biopsies (2018) (136)
- Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture (1995) (136)
- Human papillomavirus--the most significant risk determinant of cervical intraepithelial neoplasia. (1997) (135)
- Loss of antigenicity in stored sections of breast cancer tissue microarrays. (2004) (134)
- Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. (2009) (133)
- Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors. (1998) (129)
- Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. (2003) (129)
- A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study (2011) (128)
- Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. (1998) (127)
- Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. (2004) (125)
- Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. (2010) (124)
- Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer (2010) (124)
- Genetic polymorphisms in the one‐carbon metabolism pathway and breast cancer risk: A population‐based case–control study and meta‐analyses (2007) (123)
- Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 (2016) (122)
- Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. (2006) (120)
- 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. (2012) (115)
- Atypical glandular cells of undetermined significance (AGUS): Interobserver reproducibility in cervical smears and corresponding thin-layer preparations. (2002) (114)
- Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing (1997) (113)
- Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer. (2004) (113)
- Metabolic Syndrome and Risk of Endometrial Cancer in the United States: A Study in the SEER–Medicare Linked Database (2015) (112)
- Human papillomavirus—the most significant risk determinant of cervical intraepithelial neoplasia (1996) (111)
- Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions. (2003) (111)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
- Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens (1997) (108)
- Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. (2001) (107)
- Ovarian cancer risk factors by histologic subtypes in the NIH‐AARP diet and health study (2012) (106)
- Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (2011) (101)
- Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199. (2014) (101)
- Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study (2010) (100)
- Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer (2008) (100)
- The 2001 Bethesda system: Terminology for reporting results of cervical cytology (2002) (99)
- Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop. (2013) (98)
- Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan (2007) (96)
- Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States (2002) (96)
- The role of genetic breast cancer susceptibility variants as prognostic factors. (2012) (95)
- Human Papillomavirus Cofactors by Disease Progression and Human Papillomavirus Types in the Study to Understand Cervical Cancer Early Endpoints and Determinants (2009) (95)
- Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials (2017) (95)
- Hormone Receptor Immunohistochemistry and Human Papillomavirus In Situ Hybridization Are Useful for Distinguishing Endocervical and Endometrial Adenocarcinomas (2002) (92)
- Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias. (2003) (91)
- Endometrial Carcinoma Risks among Menopausal Estrogen plus Progestin and Unopposed Estrogen Users in a Cohort of Postmenopausal Women (2005) (90)
- Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. (2011) (90)
- Different risk factor patterns for high‐grade and low‐grade intraepithelial lesions on the cervix among HPV‐positive and HPV‐negative young women (1998) (88)
- Recent changes in endometrial cancer trends among menopausal-age U.S. women. (2013) (88)
- Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study. (2013) (87)
- Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica (2004) (86)
- High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression? (1992) (85)
- Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. (2014) (85)
- Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,. (2004) (85)
- Learning to detect lymphocytes in immunohistochemistry with deep learning (2019) (82)
- Serum concentrations of IGF‐I, IGFBP‐3 and c‐peptide and risk of hyperplasia and cancer of the breast in postmenopausal women (2004) (81)
- Pathology of Breast andOvarian Cancers among BRCA 1 and BRCA 2 Mutation Carriers : Results from the Consortium of Investigators of Modi fi ers of BRCA 1 / 2 ( CIMBA ) (2011) (78)
- Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification (2016) (78)
- Results of Human Papillomavirus DNA Testing with the Hybrid Capture 2 Assay Are Reproducible (2002) (77)
- Epidemiologic determinants of seroreactivity to human papillomavirus (HPV) type 16 virus-like particles in cervical HPV-16 DNA-positive and-negative women. (1996) (76)
- A population-based study of vaginal human papillomavirus infection in hysterectomized women. (2004) (76)
- Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. (2009) (75)
- Immunostaining of small cytologic specimens. Facilitation with cell transfer. (1994) (75)
- "ASCUS, rule out HSIL": cytologic features, histologic correlates, and human papillomavirus detection. (1999) (73)
- PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma. (2008) (72)
- Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies (2008) (71)
- Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons. (2015) (71)
- Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. (2008) (70)
- A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer. (2003) (70)
- Tumor Intrinsic Subtype Is Reflected in Cancer-Adjacent Tissue (2014) (70)
- Serum concentrations of estrogens, sex hormone‐binding globulin, and androgens and risk of breast cancer in postmenopausal women (2006) (69)
- Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. (2014) (69)
- Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. (2012) (68)
- Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. (2002) (68)
- Human papillomavirus, anal squamous intraepithelial lesions, and human immunodeficiency virus in a cohort of gay men. (1998) (67)
- Expression of TGF-β signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics (2010) (67)
- Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions. (1999) (67)
- Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States. (2013) (67)
- The Bethesda interobserver reproducibility study (BIRST) (2006) (65)
- Evaluation of candidate methylation markers to detect cervical neoplasia. (2007) (65)
- Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? (2013) (65)
- Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences. (2017) (65)
- The Natural History of Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia Among Young Women in the Guanacaste Cohort Shortly After Initiation of Sexual Life (2007) (65)
- Comparison between Prototype Hybrid Capture 3 and Hybrid Capture 2 Human Papillomavirus DNA Assays for Detection of High-Grade Cervical Intraepithelial Neoplasia and Cancer (2003) (65)
- Leukocyte telomere length in a population-based case–control study of ovarian cancer: a pilot study (2009) (64)
- Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer (2015) (63)
- Performance of liquid-based, thin-layer cervical cytology: correlation with reference diagnoses and human papillomavirus testing. (1998) (63)
- Adulthood Lifetime Physical Activity and Breast Cancer (2008) (63)
- Effects of HIV-1 and herpes simplex virus type 2 infection on lymphocyte and dendritic cell density in adult foreskins from Rakai, Uganda. (2011) (63)
- High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database (2016) (63)
- Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix. (1996) (61)
- Prognostic gene expression signature for high-grade serous ovarian cancer (2020) (61)
- Deep learning-based assessment of tumor-associated stroma for diagnosing breast cancer in histopathology images (2017) (61)
- Intrauterine devices and endometrial cancer risk: A pooled analysis of the Epidemiology of Endometrial Cancer Consortium (2014) (60)
- Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions (2007) (60)
- Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (2012) (60)
- Progesterone and breast cancer. (2020) (60)
- Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study. (2007) (60)
- Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages (2014) (58)
- Relationship of Mammographic Density and Gene Expression: Analysis of Normal Breast Tissue Surrounding Breast Cancer (2013) (57)
- Cytoplasmic Estrogen Receptor in Breast Cancer (2011) (57)
- Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups (2016) (57)
- Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET Testing System). (1997) (56)
- Detection of Somatic Mutations by High-Resolution DNA Melting (HRM) Analysis in Multiple Cancers (2011) (56)
- DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations (2009) (56)
- Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. (2010) (56)
- Cervicography screening for cervical cancer among 8460 women in a high-risk population. (1999) (56)
- Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer. (2015) (55)
- Discovery and validation of methylation markers for endometrial cancer (2014) (55)
- Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: A population‐based analysis (2007) (55)
- Telomerase activity in ductal carcinoma in situ and invasive breast cancer (1999) (54)
- Impact of hysterectomy on endometrial carcinoma rates in the United States. (2005) (54)
- Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda (2009) (54)
- Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach. (2017) (54)
- Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial. (2000) (53)
- Medication use and risk of ovarian carcinoma: A prospective study (2004) (53)
- The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: A Unique Resource for Defining the “Molecular Histology” of the Breast (2012) (52)
- Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients (2017) (52)
- Using Speed of Sound Imaging to Characterize Breast Density. (2017) (51)
- Reproductive risk factors for endometrial cancer among Polish women (2007) (51)
- Human Papillomavirus (HPV) Genotyping Using Paired Exfoliated Cervicovaginal Cells and Paraffin-Embedded Tissues To Highlight Difficulties in Attributing HPV Types to Specific Lesions (2007) (51)
- Endometrial cancer chemoprevention: Implications of diverse pathways of carcinogenesis (1995) (51)
- Assessment of Automated Image Analysis of Breast Cancer Tissue Microarrays for Epidemiologic Studies (2010) (50)
- Antibodies Against Chlamydia trachomatis and Ovarian Cancer Risk in Two Independent Populations (2019) (50)
- Salpingitis, Salpingoliths, and Serous Tumors of the Ovaries: Is There a Connection? (2002) (49)
- Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast (2014) (49)
- HPV DNA Testing in Cervical Cancer Screening: Results From Women in a High-Risk Province of Costa Rica (2000) (49)
- Tobacco smoking, NAT2 acetylation genotype and breast cancer risk (2006) (48)
- Current challenges and opportunities for research on borderline ovarian tumors. (2004) (48)
- A role for XRCC2 gene polymorphisms in breast cancer risk and survival (2011) (48)
- Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study (2007) (47)
- PAPNET analysis of reportedly negative smears preceding the diagnosis of a high-grade squamous intraepithelial lesion or carcinoma. (1994) (47)
- The value of multiple preparations in the diagnosis of malignant pleural effusions. A cost-benefit analysis. (1991) (46)
- Histopathologic features of ovaries at increased risk for carcinoma. A case-control analysis. (1999) (46)
- Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial (2017) (46)
- A nested case-control study of dietary factors and the risk of incident cytological abnormalities of the cervix. (1998) (46)
- Semiquantitative Human Papillomavirus Type 16 Viral Load and the Prospective Risk of Cervical Precancer and Cancer (2005) (46)
- Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study. (2004) (45)
- Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes. (2010) (45)
- Proceedings of the second international molecular pathological epidemiology (MPE) meeting (2015) (45)
- Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer (2019) (45)
- The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses. (1992) (44)
- Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease. (1997) (44)
- Pathological characteristics of cervical adenocarcinoma in a multi-center U.S.-based study (2006) (44)
- Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study. (2012) (44)
- Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis (2015) (43)
- E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium (2018) (43)
- Short Communication Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection: Results from a Population-Based Study in Costa Rica (2004) (43)
- Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case–control study from Poland (2010) (43)
- Correlates of IL-10 and IL-12 Concentrations in Cervical Secretions (2003) (43)
- Cervical Tissue Collection Methods for RNA Preservation: Comparison of Snap-frozen, Ethanol-fixed, and RNAlater-fixation (2006) (43)
- Determinants of seropositivity among HPV-16/18 DNA positive young women (2010) (43)
- ERβ splice variant expression in four large cohorts of human breast cancer patient tumors (2014) (42)
- Microsatellite instability is infrequent in medullary breast cancer. (2001) (42)
- Focal fibrosis of the breast: imaging characteristics and histopathologic correlation. (2000) (42)
- Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study (2012) (42)
- The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents. (2015) (41)
- Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers (2012) (41)
- Sexual Behavior, Human Papillomavirus Type 16 (HPV 16) Infection, and HPV 16 Seropositivity (2002) (41)
- Relationships of sex steroid hormone levels in benign and cancerous breast tissue and blood: A critical appraisal of current science (2015) (41)
- Qualitative age interactions in breast cancer studies: mind the gap. (2009) (41)
- Family history as a co‐factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: Results from two studies conducted in Costa Rica and the United States (2005) (40)
- Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan (2012) (40)
- Single Nucleotide Polymorphisms in the PRDX3 and RPS19 and Risk of HPV Persistence and Cervical Precancer/Cancer (2012) (39)
- Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case–control study (2016) (39)
- Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer. (2016) (39)
- Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival Heterogeneity (2019) (38)
- Cytologic diagnosis of anal intraepithelial neoplasia using smears and cytyc thin-preps. (1995) (38)
- 11q13 is a susceptibility locus for hormone receptor positive breast cancer (2012) (38)
- Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue respository of the Surveillance, Epidemiology, and End Results (SEER) program (2008) (38)
- Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review (2012) (38)
- Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status (2014) (37)
- Reproducibility of Biopsy Diagnoses of Endometrial Hyperplasia: Evidence Supporting a Simplified Classification (2008) (37)
- Long‐term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment (2012) (37)
- Occupational exposure to organic solvents and breast cancer in women (2009) (37)
- Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities (2015) (37)
- Prospects for a prophylactic HPV vaccine: Rationale and future implications for cervical cancer screening (1998) (37)
- Alcohol Consumption and Survival after a Breast Cancer Diagnosis: A Literature-Based Meta-analysis and Collaborative Analysis of Data for 29,239 Cases (2014) (36)
- Investigation of gene‐environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors (2015) (35)
- Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women (2011) (34)
- Heterogeneity of high‐grade cervical intraepithelial neoplasia related to HPV16: Implications for natural history and management (2013) (34)
- Multivariate analysis of prognostic features in malignant pleural effusions from breast cancer patients. (1994) (34)
- Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer (2011) (33)
- Utility of immediate on‐site cytopathological procurement and evaluation in fine needle aspiration biopsy of head and neck masses (1992) (33)
- Molecular Pathology in Epidemiologic Studies: A Primer on Key Considerations (2010) (32)
- Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries (2018) (32)
- Stereotactic brain biopsy in the diagnosis of malignant lymphoma. (1991) (31)
- PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors (2015) (31)
- Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (2014) (31)
- Benign Breast Tissue Composition in Breast Cancer Patients: Association with Risk Factors, Clinical Variables, and Gene Expression (2014) (30)
- Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial. (2015) (30)
- Absolute risk models for subtypes of breast cancer. (2007) (30)
- Human Papillomavirus Load Measured by Linear Array Correlates with Quantitative PCR in Cervical Cytology Specimens (2012) (30)
- Seroprevalence and Correlates of Human Papillomavirus 16/18 Seropositivity Among Young Women in Costa Rica (2010) (29)
- Fine-needle aspiration biopsy of cervicofacial masses in children. (1995) (29)
- Intake of fruits, and vegetables in relation to breast cancer risk by hormone receptor status (2007) (28)
- Accuracy of cervical specimens obtained for biomarker studies in women with CIN3. (2009) (28)
- Quantitative assessment of miR34a as an independent prognostic marker in breast cancer (2014) (28)
- Prolactin Receptor Expression and Breast Cancer: Relationships with Tumor Characteristics among Pre- and Post-menopausal Women in a Population-Based Case–Control Study from Poland (2014) (27)
- Diagnosis of progressive multifocal leukoencephalopathy by stereotactic brain biopsy utilizing immunohistochemistry and the polymerase chain reaction. (1995) (27)
- Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women (2006) (27)
- Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE) (2020) (27)
- Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository (2013) (26)
- Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma. (1990) (26)
- Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer (2013) (26)
- Post-diagnosis adiposity and survival among breast cancer patients: influence of breast cancer subtype (2015) (26)
- Weight, height, and body mass index and risk for ovarian cancer in a cohort study. (2006) (26)
- Comparison of Mammographic Density Assessed as Volumes and Areas among Women Undergoing Diagnostic Image-Guided Breast Biopsy (2014) (26)
- Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study. (2011) (26)
- Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors (2016) (26)
- Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype (2015) (25)
- Human leukocyte antigen class I and II haplotypes and risk of cervical cancer. (2005) (25)
- Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis (2009) (25)
- Active and passive cigarette smoking and the risk of endometrial cancer in Poland. (2010) (25)
- Direct Comparison of HPV16 Serological Assays Used to Define HPV-Naïve Women in HPV Vaccine Trials (2012) (24)
- Relationships of uterine and ovarian tumors to pre-existing chronic conditions. (2007) (24)
- Current and Future Methods for Measuring Breast Density: A Brief Comparative Review. (2015) (24)
- Diagnosis of thymoma by needle biopsy. (1990) (24)
- Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms. (2020) (24)
- Longitudinal Change in Mammographic Density among ER-Positive Breast Cancer Patients Using Tamoxifen (2015) (24)
- Epidemiologic analysis of histologic cervical inflammation: relationship to human papillomavirus infections. (2008) (24)
- Determinants of the reliability of ultrasound tomography sound speed estimates as a surrogate for volumetric breast density. (2015) (24)
- Association between mammographic breast density and histologic features of benign breast disease (2017) (23)
- Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium (2014) (23)
- Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study. (2007) (23)
- Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland (2011) (23)
- High‐throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium (2016) (23)
- HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer (2020) (23)
- Multilocular renal cyst. A hamartoma with potential for neoplastic transformation? (1987) (22)
- Chapter 11: Future directions in cervical pathology. (2003) (22)
- Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170 (2016) (22)
- The Bethesda System (1993) (22)
- Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast (2014) (22)
- A case–control study of endogenous hormones and cervical cancer (2004) (21)
- An Expanded Sequence Context Model Broadly Explains Variability in Polymorphism Levels Across the Human Genome (2016) (21)
- Can cervicography be improved? An evaluation with arbitrated cervicography interpretations. (2002) (21)
- Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression (2013) (21)
- Vaginal intraepithelial neoplasia. Reproducibility of pathologic diagnosis and correlation of smears and biopsies. (1993) (21)
- Measurement of Sex Steroid Hormones in Breast Adipocytes: Methods and Implications (2008) (21)
- What Is Inflammatory Breast Cancer? Revisiting the Case Definition (2010) (20)
- Divergent oestrogen receptor-specific breast cancer trends in Ireland (2004-2013): Amassing data from independent Western populations provide etiologic clues. (2017) (20)
- Mammographic Density as a Biosensor of Tamoxifen Effectiveness in Adjuvant Endocrine Treatment of Breast Cancer: Opportunities and Implications. (2016) (20)
- Advances in endometrial pathology. (1995) (20)
- Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial. (2015) (20)
- Cell-Cycle Protein Expression in a Population-Based Study of Ovarian and Endometrial Cancers (2015) (20)
- Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci (2017) (19)
- Analysis of serial ovarian volume measurements and incidence of ovarian cancer: implications for pathogenesis. (2014) (19)
- Breast cancer risk in older women: results from the NIH-AARP Diet and Health Study (2014) (19)
- Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation (2018) (19)
- Intrauterine environment and breast cancer risk in a population‐based case‐control study in Poland (2006) (19)
- Quantitative analysis of TDLUs using adaptive morphological shape techniques (2013) (19)
- Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study (2017) (19)
- Ovarian neoplasia: epidemiology and etiology (2009) (18)
- Performance of cytology and human papillomavirus testing in relation to the menstrual cycle (2006) (18)
- Breast cancer etiology by estrogen and progesterone receptors status: a review (2003) (18)
- Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease (2016) (18)
- Evaluation of the Polyclonal ELISA HPV Serology Assay as a Biomarker for Human Papillomavirus Exposure (2011) (18)
- Population Frequency of Serous Tubal Intraepithelial Carcinoma (STIC) in Clinical Practice Using SEE-Fim Protocol. (2018) (18)
- A prospective clinical cohort study of women at increased risk for endometrial cancer. (2019) (18)
- Evaluation of PAPNET testing as an ancillary tool to clarify the status of the "atypical" cervical smear. (1997) (17)
- Rapid identification of patient specimens with microsatellite DNA markers. (1996) (17)
- Serum Concentrations of Estrogens, Sex Hormone Binding Globulin, and Androgens and Risk of Breast Hyperplasia in Postmenopausal Women (2005) (17)
- Ovarian Volume: Determinants and Associations with Cancer among Postmenopausal Women (2006) (17)
- Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage. (2002) (17)
- Using Whole Breast Ultrasound Tomography to Improve Breast Cancer Risk Assessment: A Novel Risk Factor Based on the Quantitative Tissue Property of Sound Speed (2020) (17)
- Evaluation of Linear Array Human Papillomavirus Genotyping Using Automatic Optical Imaging Software (2008) (17)
- Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors. (1998) (17)
- Breast density measurements using ultrasound tomography for patients undergoing tamoxifen treatment (2013) (16)
- Detection of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White women with breast cancer (2020) (16)
- The Bethesda System. Impact on reporting cervicovaginal specimens and reproducibility of criteria for assessing endocervical sampling. (1993) (15)
- Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials (2018) (15)
- Evolving concepts in endometrial carcinogenesis: importance of DNA repair and deregulated growth. (1998) (15)
- Neither one‐time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer (2009) (15)
- Clinical and Pathological Heterogeneity of Cervical Intraepithelial Neoplasia Grade 3 (2012) (15)
- Skewed X chromosome inactivation and early-onset breast cancer (2005) (15)
- Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes (2019) (15)
- Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection. (2019) (15)
- Construction and Validation of Tissue Microarrays of Ductal Carcinoma In Situ and Terminal Duct Lobular Units Associated With Invasive Breast Carcinoma (2006) (15)
- Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data (2009) (15)
- Clarifying breast cancer risks associated with menopausal hormone therapy. (2006) (14)
- Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates. (2014) (14)
- Endometrial thickness and risk of breast and endometrial carcinomas in the prostate, lung, colorectal and ovarian cancer screening trial (2014) (14)
- Pro-inflammatory cytokines and growth factors in human milk: an exploratory analysis of racial differences to inform breast cancer etiology (2018) (14)
- THEORIES OF ENDOMETRIAL CARCINOGENESIS (2000) (14)
- Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica. (1999) (14)
- Future directions in cervical pathology (2003) (14)
- The role of exfoliative cytology and histopathology in screening and triage. (1996) (13)
- Recurrent serous borderline tumors of the ovary. (1998) (13)
- Accurate identification of breast cancer margins in microenvironments of ex-vivo basal and luminal breast cancer tissues using Raman spectroscopy. (2020) (13)
- Cytopathology of pleural effusions after radiotherapy. (1994) (13)
- Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices. (2018) (12)
- Application of convolutional neural networks to breast biopsies to delineate tissue correlates of mammographic breast density (2019) (12)
- Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy (2016) (12)
- Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome (2013) (12)
- Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors (2017) (12)
- Potential of breastmilk analysis to inform early events in breast carcinogenesis: rationale and considerations (2016) (12)
- A seroepidemiologic study of HPV infection and incident cervical squamous intraepithelial lesions. (1994) (12)
- Digital and Computational Pathology: Bring the Future into Focus (2019) (12)
- Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer. (2020) (11)
- Racial Disparities in Breast Cancer Outcomes in the Metropolitan Atlanta Area: New Insights and Approaches for Health Equity (2019) (11)
- Erratum: Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies (Journal of Clinical Microbiology (1998) 36:11 (3248-3254)) (1999) (11)
- Single Nucleotide Polymorphisms in the TP 53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer (2009) (11)
- Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis (2015) (11)
- Greater absolute risk for all subtypes of breast cancer in the US than Malaysia (2014) (11)
- Relationship of Serum Estrogens and Metabolites with Area and Volume Mammographic Densities (2015) (11)
- Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesions. (1997) (10)
- Mammary collagen architecture and its association with mammographic density and lesion severity among women undergoing image-guided breast biopsy (2021) (10)
- Reproducibility of Linear Array for Human Papillomavirus Genotyping (2012) (10)
- Pathologic evaluation of gynecologic specimens obtained with the cavitron ultrasonic surgical aspirator (CUSA). (1992) (10)
- Uterine serous carcinoma: Reassessing effectiveness of platinum-based adjuvant therapy. (2018) (10)
- Cervicography Screening for Cervical Cancer Among 8,460 Women in a High-Risk Population (1999) (10)
- Alcohol and endometrial cancer risk in the NIH‐AARP diet and health study (2011) (10)
- Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort (2019) (9)
- NanoString-based breast cancer risk prediction for women with sclerosing adenosis (2017) (9)
- Serum insulin‐like growth factor (IGF)‐I and IGF binding protein‐3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank (2018) (9)
- Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. (2011) (9)
- Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in Cancer Prevention Study-II (2019) (9)
- Relationships between mammographic density, tissue microvessel density, and breast biopsy diagnosis (2016) (9)
- Utility of gastric brushing in the diagnosis of malignant lymphoma. (1994) (9)
- Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199). (2019) (9)
- New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future research. (2012) (9)
- Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast (2017) (9)
- Atypical Squamous Cells (2015) (9)
- Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones. (2007) (8)
- Association of serum sex steroid hormone hemodilution and body mass index among healthy postmenopausal women. (2011) (8)
- Ogino et Al. Respond to "the 21st century epidemiologist". (2012) (8)
- The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource (2016) (8)
- Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence (2016) (8)
- Stroma modifies relationships between risk factor exposure and age-related epithelial involution in benign breast (2018) (8)
- Estrogen Replacement Therapy and Risk of Ovarian Cancer in Postmenopausal Women—Reply (2002) (8)
- Detection of endometrial cancer cells in the fallopian tube lumen is associated with adverse prognostic factors and reduced survival. (2018) (8)
- Comparison of sound speed measurements on two different ultrasound tomography devices (2014) (7)
- Emerging Concepts in Breast Cancer Risk Prediction (2013) (7)
- Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers (2015) (7)
- BRCA1/2 and Endometrial Cancer Risk: Implications for Management. (2021) (7)
- Involution of Breast Lobules, Mammographic Breast Density and Prognosis Among Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer Patients (2019) (7)
- Ultrasound tomography imaging with waveform sound speed: parenchymal changes in women undergoing tamoxifen therapy (2017) (7)
- From Papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination. (2013) (6)
- Opportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: interdisciplinary approaches. (2014) (6)
- Lobular involution, mammographic density, and breast cancer risk: visualizing the future? (2010) (6)
- Reclassification of negative smears as atypical squamous cells of undetermined significance in quality assurance reviews (1999) (6)
- Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue (2016) (6)
- Chapter 14 – Epidemiology of Uterine Corpus Cancers (2004) (6)
- Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (6)
- Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality. (2012) (6)
- 7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium (2011) (6)
- Common breast cancer risk loci predispose to distinct tumor subtypes (2019) (6)
- Comparison of breast density measurements made using ultrasound tomography and mammography (2015) (6)
- Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients (2015) (6)
- Sex Hormones, Insulin, and Insulin-like Growth Factors in Recurrence of High-Stage Endometrial Cancer (2021) (5)
- Breast cancer risk factors by mode of detection among screened women in the Cancer Prevention Study-II (2019) (5)
- The relationship between terminal duct lobular unit features and mammographic density among Chinese breast cancer patients (2019) (5)
- Beyond Breast Cancer: Mammographic Features and Mortality Risk in a Population of Healthy Women (2013) (5)
- Protein-based immune profiles of basal-like vs. luminal breast cancers (2020) (5)
- Towards Improved Biomarker Studies of Cervical Neoplasia: Effects of Precolposcopic Procedures on Gene Expression Patterns (2005) (5)
- Comparison of PCR- and Hybrid Capture-Based Human Papillomavirus Detection Systems Using Multiple Cervical Specimen Collection Strategies (1999) (5)
- Immune Responses and Risk of Triple-negative Breast Cancer: Implications for Higher Rates among African American Women (2020) (5)
- The Use of Fine-Needle Aspiration in the Diagnosis of Metastatic Pulmonary Adenoid Cystic Carcinoma (1991) (5)
- Intercepting Endometrial Cancer: Opportunities to Expand Access Using New Technology (2020) (5)
- Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a “Traceback” approach (2018) (5)
- Evaluation of 2 breast cancer risk models in a benign breast disease cohort (2018) (5)
- Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups (2016) (4)
- Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients (2016) (4)
- Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy (2020) (4)
- Genetic variation at CYP 3 A is associated with age at menarche and breast cancer risk : a case-control study (2014) (4)
- Relationship of circulating insulin-like growth factor-I and binding proteins 1–7 with mammographic density among women undergoing image-guided diagnostic breast biopsy (2019) (4)
- Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (2012) (4)
- Right-Sided Ectocervical Lesions May Be Associated with False-Negative Cytology Among Women with Histologic Cervical Intraepithelial Neoplasia 2 or 3 (2003) (4)
- Pathologic findings at risk-reducing salpingo-oophorectomy among women at increased ovarian cancer risk: Results from GOG-199. (2012) (4)
- Bimodal breast cancer incidence patterns provide support for a dualistic model of mammary carcinogenesis. (2006) (4)
- The cost of diagnosing endometrial cancer: Quantifying the healthcare cost of an abnormal uterine bleeding workup. (2021) (4)
- Morphological and molecular classification of human cancer (2017) (4)
- High-Risk Human Papillomavirus Is Sexually Transmitted : Evidence from a Follow-Up Study of Virgins Starting Sexual Activity ( Intercourse ) 1 (2001) (3)
- Risk Factors for NON-HPV16/18 Cervical Infections and Associated Lesions Among HPV-DNA-Negative Women Vaccinated Against HPV16/18 in the Costa Rica Vaccine Trial (CVT). (2020) (3)
- Characterization of human breast cancer by scanning acoustic microscopy (2013) (3)
- Relationship of Serum Progesterone and Progesterone Metabolites with Mammographic Breast Density and Terminal Ductal Lobular Unit Involution among Women Undergoing Diagnostic Breast Biopsy (2020) (3)
- Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learning (2022) (3)
- Cervix: epidemiology of squamous neoplasia (2009) (3)
- Differences in Genome-wide DNA Methylation Profiles in Breast Milk by Race and Lactation Duration (2019) (3)
- Abstract 4682: Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease (2015) (3)
- Disparities and interventions in the timeliness of endometrial cancer diagnosis and treatment in the United States: a scoping review protocol (2021) (3)
- Oncocytic nodule. An unusual case of a submaxillary gland mass in an elderly patient. (1990) (3)
- Update on recent clinical studies using HPV testing for screening and diagnosis of cervical neoplasia (2000) (3)
- Quantifying procedural pain associated with office gynecologic tract sampling methods. (2021) (3)
- Learning from disease heterogeneity. (2012) (3)
- Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility. (2020) (3)
- Leukocyte telomere length and its association with mammographic density and proliferative diagnosis among women undergoing diagnostic image-guided breast biopsy (2015) (3)
- Serum insulin-like growth factor ( IGF )-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women : The (2018) (2)
- Rapid Reductions in Breast Density following Tamoxifen Therapy as Evaluated by Whole-Breast Ultrasound Tomography (2022) (2)
- “Sip volume” as a quality indicator in liquid‐based cervical cytology (2006) (2)
- Molecular and clinical characterization of postpartum-associated breast cancer in the Carolina Breast Cancer Study Phase I-III, 1993-2013. (2021) (2)
- Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options (2021) (2)
- Abstract 3838: Differential expression of Notch1 in lung, ovarian and breast cancers (2014) (2)
- Plus : development and validation of a prognostic model for early breast cancer that includes HER 2 (2012) (2)
- Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers (2012) (2)
- Abstract 385: Tamoxifen-resistant breast cancer: DNA methylation and expression of MAGED1 (2014) (2)
- Development of novel home-based tampon sampling for endometrial cancer: findings from community-based focus groups with Black and White women (2021) (2)
- Annexin A 1 expression in a pooled breast cancer series (2)
- Abstract 4465: Breast cancer risk factor associations with breast tissue morphometry: results from the Komen for the Cure® Tissue Bank (2012) (2)
- Using ultrasound tomography to identify the distributions of density throughout the breast (2016) (2)
- Soluble Interleukin 2 Receptor Levels and Cervical Neoplasia (1999) (2)
- Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium: Automated scoring of breast tumor TMAs (2014) (2)
- Evaluation of E-cadherin expression and lymphatic involvement in inflammatory breast cancer (2006) (2)
- Qualification of ASCUS. Authors' reply (2002) (2)
- Somatic mutations in benign breast disease tissues and association with breast cancer risk (2021) (1)
- Abstract 266: How many epidemiological types of breast cancer: Two, three, four, or more (2014) (1)
- Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (2014) (1)
- Detection of perforin in human peritoneal fluid T-lymphocytes. (1996) (1)
- Discovery and validation of novel DNA methylation markers for the detection of endometrial cancer: Selection by methylome-wide analysis (2019) (1)
- Menopausal estrogen therapy and endometrial cancer in a US cohort: recency and potential interactions with other risk factors (2003) (1)
- Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status (2014) (1)
- Lower Exome Sequencing Coverage of Ancestrally African Patients in The Cancer Genome Atlas (2022) (1)
- Abstract 4942: Serologic markers of infectious agents and ovarian cancer: Markers of priorChlamydia trachomatisinfection associated with increased ovarian cancer risk in two independent populations (2018) (1)
- Abstract 588: Relationship of serum progesterone and progesterone metabolites with mammographic density (2019) (1)
- Automated Scoring of Nuclear Pleomorphism Spectrum with Pathologist-level Performance in Breast Cancer (2020) (1)
- Abstract A32: Patterns of longitudinal change in mammographic density among tamoxifen users (2013) (1)
- Abstract P3-08-02: Common variants at 10p14 and 1p11.2 display heterogeneity in breast cancer associations by E-cadherin tumor tissue expression in two independent datasets (2012) (1)
- Abstract 870: Analysis of breast cancer risk factors by expression of tumor markers: results of 34 studies in the Breast Cancer Association Consortium (BCAC) (2010) (1)
- Abstract 2779: Relationship of mammographic density with breast cancer subtypes (2010) (1)
- Reply to m.j. Mourits et Al. (2015) (1)
- Effect of Risk-Reducing Salpingo-Oophorectomy on Sex-Steroid Hormone Serum Levels among Post-Menopausal Women: An NRG Oncology/GOG Study. (2022) (1)
- Associations of Genetic Ancestry with Terminal Duct Lobular Unit Involution among Healthy Women. (2022) (1)
- Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk—Letter (2021) (1)
- Analysis of Histopathological Features of Endometrioid Uterine (2012) (1)
- Implications of the obesity epidemic for endometrial cancer risk, mortality, and survivorship. (2021) (1)
- Relationships of tubal ligation to endometrial carcinoma stage and mortality in the NRG oncology/gynecologic oncology group 210 trial (2015) (1)
- Effect of Nonionic Detergents on Amplification of Human Papillomavirus DNA with Consensus Primers MY09 and MY11 (1998) (1)
- Protocol for the Detection of Organoid-Initiating Cell Activity in Patient-Derived Single Fallopian Tube Epithelial Cells. (2022) (1)
- Identifying Women With Cervical Neoplasia Using Human Papillomavirus DNA Testing for Equivocal Papanicolaou Results (1999) (1)
- pAKT expression in paraffin-embedded xenograft tumors after fixation delays and human breast cancer by optimized immunohistochemistry. (2012) (1)
- Erratum: Effects of age and human papilloma viral load on colposcopy triage: Data from the randomized atypical squamous cells of undetermined significance/low-grade squamous Intraepithelial Lesion Triage Study (ALTS) (Journal of Lower Genital Tract Disease (2002) 94 (1020-1107)) (2008) (1)
- Barcoded Competitive Clone-Initiating Cell (BC-CIC) Analysis Reveals Differences in Ovarian Cancer Cell Genotype and Niche Specific Clonal Fitness During Growth and Metastasis In Vivo (2021) (1)
- Computational disease progression modeling can provide insights into cancer evolution (2020) (1)
- Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer. (2022) (1)
- Abstract 861: Relationships of prolactin serum levels to breast cancer risk and tumor characteristics in a population-based case-control study from Poland (2010) (0)
- Abstract 4662: Framework for clinical evaluation of chemopreventive agents: Defining criteria for future assessment (2015) (0)
- Application of convolutional neural networks to breast biopsies to delineate tissue correlates of mammographic breast density (2019) (0)
- Abstract 117: Association of TGF-β2 levels in breast milk with breast biopsy diagnosis. (2013) (0)
- Leukocyte telomere length and its association with mammographic density and proliferative diagnosis among women undergoing diagnostic image-guided breast biopsy (2015) (0)
- Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease (2016) (0)
- Front & Back Matter (2012) (0)
- Abstract C053: Identification of factors contributing to breast cancer mortality disparities in the metropolitan Atlanta area (2020) (0)
- Abstract B41: Methylation profiling of ovarian cancer to study etiologic and prognostic heterogeneity and to develop a molecular classifier. (2016) (0)
- Abstract 152: Endometrial thickness and risk of sex hormone-related cancers in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. (2013) (0)
- Papillomavirus Genotyping Reproducibility of Linear Array for Human (2014) (0)
- Abstract 4235: Application of convolutional neural networks to breast biopsies to uncover tissue correlates of mammographic breast density (2017) (0)
- Serum hormone levels and normal breast histology among premenopausal women (2022) (0)
- Residents Page: Pathology (1993) (0)
- Pathologic quiz case 1. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). (1993) (0)
- Abstract 2971: Digital image analysis based IHC4+C assay and prognosis in hormone receptor-positive breast cancer (2018) (0)
- Abstract 3700: Incidence trends of breast, endometrial, and ovarian cancer among US women in relation to changing patterns of menopausal hormone therapy (2015) (0)
- Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification (2016) (0)
- Abstract 2203: A prospective study of endometrial cancer detection in women presenting for evaluation of abnormal peri- and postmenopausal bleeding (2018) (0)
- Post-diagnosis adiposity and survival among breast cancer patients: influence of breast cancer subtype (2015) (0)
- Abstract 4722: Evaluation of common genetic variation in 1,300 cancer-related candidate genes and endometrial cancer risk (2010) (0)
- Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors (2016) (0)
- Abstract 4635: Analysis of post-partum breast tissue to understand early onset breast cancer (2020) (0)
- Abstract P2-11-01: Breast cancer (BC) risk among patients with benign breast disease (BBD) by NSAID use (2022) (0)
- Abstract 4250: DNA methylation portraits of breast cancer in a population-based cohort. (2013) (0)
- Postmenopausal estrogen-only, but not estrogen + progestin, was associated with an increased risk of ovarian cancer (2003) (0)
- Abstract 2786: Methylation profiling of endometrial cancers from a population-based case control study (2010) (0)
- Abstract 5012: DNA methylation profiles of endometrial cancer and benign endometrium suggest differences by mismatch repair status and possible early detection markers (2012) (0)
- Abstract 874: Autoantibody biomarker discovery in basal-like breast cancer using nucleic acid programmable protein array (2014) (0)
- Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium (2020) (0)
- Abstract 1818: Gene expression profiling to understand stages in breast cancer development and progression: importance of tissue sampling and context . (2013) (0)
- Abstract 651: Analysis of the immune microenvironment to advance breast cancer risk prediction and prevention (2019) (0)
- A Comparison of Single and Combined Visual , Cytologic , and Virologic Tests as Screening Strategies in a Region at High Risk of Cervical Cancer 1 (2003) (0)
- Abstract P3-12-05: Genetic Variation in Prolactin and Prolactin Receptor, and Relationships with Serum Prolactin Levels and Breast Cancer Risk (2010) (0)
- Proceedings of the second international molecular pathological epidemiology (MPE) meeting (2015) (0)
- Lynch syndrome: patients’ perception of cancer risk, uptake of risk reducing surgery, and screening practices (2021) (0)
- Using Digital Pathology to Understand Epithelial Characteristics of Benign Breast Disease among Women Undergoing Diagnostic Image-Guided Breast Biopsy (2019) (0)
- Abstract LB-454: Serum metabolic profiles and endometrial cancer (2011) (0)
- Qualification of ASCUS (multiple letters) [2] (2002) (0)
- Abstract A71: Risk factors for in situ breast cancer among postmenopausal women (2011) (0)
- Abstract A81: Relationships between expression of TGF-β factors and breast tumor characteristics in a population-based study from Poland (2009) (0)
- Risk of cervical cancer in later years was increased in women with positive cytological screening, but negative histology (2001) (0)
- Reply: Study design and statistics in epidemiology of breast cancer (2006) (0)
- Abstract 257: Estrogen receptor positive and negative breast cancer secular trends in Ireland (2004-2013) (2017) (0)
- Systematic Scoping Literature Review of Disparities in Stage of Endometrial Cancer [A321] (2022) (0)
- Abstract A36: Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution in Caucasian and African American women: The Susan G. Komen Tissue Bank (2018) (0)
- IGCS 20 _ 1454 417 KRAS MUTANT UTERINE CARCINOMAS (2020) (0)
- Abstract P6-10-07: Differences in genome-wide DNA methylation levels in breast milk by race and lactation duration (2018) (0)
- Abstract 3712: Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study (2011) (0)
- Abstract 3451: Breast cancer risk factor associations by loss of E-cadherin tumor tissue expression: A pooled analysis of 5,896 cases in 12 studies from the Breast Cancer Association Consortium (BCAC) (2016) (0)
- Abstract 2274: Somatic variant burdenin benign breast disease and association with risk of subsequent breast cancer (2021) (0)
- Reproductive risk factors associated with breast cancer in young women by molecular subtype (2022) (0)
- Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review (2012) (0)
- Abstract 2203: Towards prediction of breast cancer risk in benign biopsies with high-plex GeoMx spatial protein profiling (2022) (0)
- Abstract 150: Ovarian visualization in transvaginal ultrasound scans and risk of ovarian cancer. (2013) (0)
- Abstract 4298: Cytokines and adipokines in breastmilk of black and white women (2016) (0)
- Annexin A1 expression in breast cancer: tumor subtypes and prognosis (2015) (0)
- Abstract P2-11-11: Tissue sound speed: A novel imaging biomarker for measuring tamoxifen response (2020) (0)
- Abstract 4475: Association of endometrial cancer risk factors and DNA methylation in benign endometrial tissue (2012) (0)
- Abstract 3477: Discovery and validation of methylation markers for early detection of endometrial cancer. (2013) (0)
- Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence (2022) (0)
- Weight, height, and body mass index and ovarian cancer risk in a prospective study (2004) (0)
- Mammary collagen architecture and its association with mammographic density and lesion severity among women undergoing image-guided breast biopsy (2021) (0)
- Erratum: Intrauterine environment and breast cancer risk in a population-based case-control study in Poland (International Journal of Cancer (2006) 119, (2136-2141)) (2007) (0)
- Abstract 2850: Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2: results and replication in two case-control studies (2010) (0)
- Abstract PD10-10: Epithelial proliferation score as an independent breast cancer risk predictor in benign breast disease (2021) (0)
- 30th Annual Meeting • American Society of Preventive Oncology, Bethesda, Maryland • February 26–28, 2006 (2006) (0)
- Abstract A111: Genetic variations in five estrogen metabolizing genes and endometrial cancer risk (2008) (0)
- Methylation profiling of invasive cervical carcinoma using restriction landmark genomic scanning (RLGS) (2004) (0)
- Models of endometrial carcinogenesis (2008) (0)
- Somatic mutations in benign breast disease tissues and association with breast cancer risk (2021) (0)
- Abstract 268: Absolute breast cancer risk according to three risk prediction models: Inverse associations with risk of death and poor prognostic features (2014) (0)
- Intraluminal tumor cells are associated with adverse prognostic factors and survival among women with endometrial cancer (2018) (0)
- Detection of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White women with breast cancer (2020) (0)
- Abstract 3762: Automated analysis of breast cancer tissue microarrays to investigate etiologic heterogeneity in the Breast Cancer Association Consortium (2010) (0)
- Abstract 58: Associations between breast cancer susceptibility markers and terminal duct lobular unit involution in normal breast tissues among women from the Susan G. Komen for the Cure® Tissue Bank. (2012) (0)
- Molecular and Cellular Pathobiology 19 p 13 . 1 Is a Triple-Negative – Speci fi c Breast Cancer Susceptibility Locus (2012) (0)
- Abstract PS7-11: Benign breast disease: Temporal trends from 1967 to 2013 (2021) (0)
- Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis (2015) (0)
- Abstract 3488: Associations of circulating hormones with mammographic density in postmenopausal women referred to diagnostic breast biopsy (2020) (0)
- P4-10-03: Association between BMI, Physical Activity and Breast Cancer Histologic Types. (2011) (0)
- P01.02 HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer (2020) (0)
- Abstract 2113: Discrimination of benign breast disease from normal lobules using an automated computational pathology algorithm (2020) (0)
- Abstract C074: Presence of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White breast cancer patients (2020) (0)
- Abstract 22: Prediagnostic serum levels of inflammation markers and risk of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: Preliminary results. (2012) (0)
- Abstract 5805: Treatment-associated endocrine symptoms and change in ultrasound tomography measures of breast density after tamoxifen therapy (2020) (0)
- Human Papillomavirus DNA Detection in Cervical Specimens by Hybrid Capture: Correlation with Cytologic and Histologic Diagnoses of Squamous Intraepithelial Lesion of the Cervix (1997) (0)
- Traceback: leveraging archived biospecimens to identify mutation carriers (2017) (0)
- Abstract 3260: Utilizing digital pathology to understand breast epithelial characteristics of benign breast disease among women undergoing diagnostic image-guided breast biopsy (2018) (0)
- Relationships between mammographic density, tissue microvessel density, and breast biopsy diagnosis (2016) (0)
- Abstract P5-08-06: NSAID use and breast cancer risk in a retrospective cohort of women with benign breast disease (2020) (0)
- Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution (2017) (0)
- Abstract LB-336: Association of variant rs2046210 at 6q25.1 (ESR1) with breast cancer risk suggests heterogeneity by E-cadherin tumor tissue expression (2012) (0)
- Relationship of circulating insulin-like growth factor-I and binding proteins 1–7 with mammographic density among women undergoing image-guided diagnostic breast biopsy (2019) (0)
- Abstract IA11: Life course epidemiology and breast cancer: translating risk into prevention (2017) (0)
- Breast cancer risk in older women: results from the NIH-AARP Diet and Health Study (2014) (0)
- Persistence of the same HPV type over 2 years increased 800-fold the risk of developing high-grade cervical lesions (2003) (0)
- Abstract 6333: Quantification of oxylipins as biomarkers of inflammation and cancer risk in breast tissue (2022) (0)
- Abstract 260: Incidence rates and outcomes of fallopian tube carcinomas: Data from the North American Association of Central Cancer Registries (2017) (0)
- 6 Application of Biomarkers in Cancer Epidemiology (2009) (0)
- Abstract 2767: Investigation of the relationship between crown-like structures and adipose tissue hormone levels among postmenopausal women with breast cancer (2015) (0)
- Pap smear and HPV testing in combination were more accurate than either test alone for predicting the future development of CIN3 or cervical cancer (2003) (0)
- Smoking, but not parity or OC use, increased the risk of high-grade cervical neoplasia in women infected with HPV (2003) (0)
- PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors (2015) (0)
- Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository (2013) (0)
- Tissue sound speed is more strongly associated with breast cancer risk than mammographic percent density: A comparative case-control study (2020) (0)
- BenignBreast TissueComposition inBreastCancerPatients : Association with Risk Factors , Clinical Variables , and Gene Expression (2014) (0)
- Association of rs12662670 with breast cancer in Asian ER (2012) (0)
- Abstract P2-11-14: Pathology AI features and immune biomarkers of postpartum involution: Implications for postpartum breast cancer (2022) (0)
- Abstract PO-068: Intratumoral heterogeneity of prognostic multigene signatures for breast cancer (2020) (0)
- Abstract 5570: Heterogeneity of luminal breast cancer characterized by immunohistochemical expression of basal markers (2015) (0)
- Response: Re: Recent Trends in Breast Cancer Among Younger Women in the United States (2009) (0)
- Quantifying diagnostic and etiologic management costs of perimenopausal abnormal uterine bleeding and postmenopausal bleeding (2021) (0)
- Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors (2017) (0)
- Discovery and validation of novel methylated DNA markers of cervical cancer. (2021) (0)
- Abstract 5290: Racial variation in terminal duct lobular unit (TDLU) involution in Chinese and Polish breast cancer patients (2017) (0)
- Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients (2017) (0)
- Abstract LB226: Maternal microbiome protects host against clonal de novo transformation, early onset systemic metastasis, and sudden death (2021) (0)
- Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort (2019) (0)
- Abstract P3-08-28: Tissue sound speed is more strongly associated with breast cancer risk than mammographic percent density: A comparative case-control study (2020) (0)
- Abstract 3651: Parity-related molecular signatures and breast cancer heterogeneity. (2013) (0)
- Abstract 71: Relationship of mammographic density and gene expression analysis of normal breast tissue surrounding breast cancer. (2012) (0)
- The New Molecular Biology Section of (2000) (0)
- Abstract B89: Endogenous hormone levels and lobular involution of the breast among healthy, postmenopausal women in the Komen Tissue Bank Study (2012) (0)
- Expression Association with Risk Factors , Clinical Variables , and Gene Benign Breast Tissue Composition in Breast Cancer Patients : (2014) (0)
- Abstract 2768: Relationships between mammographic density, microvessel density, and breast biopsy diagnosis (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mark E. Sherman?
Mark E. Sherman is affiliated with the following schools:
